Autopsy report · NCT04041674

Evaluating the Safety and Immunogenicity of a Prime-boost Vaccine Regimen of GEO-D02 DNA and MVA/HIV62B With and Without B63521^11 gp120 and IHV01 gp120 Env Proteins in Healthy, HIV-uninfected Adult Participants

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Protocol undergoing additional revisions.”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 1
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sponsor type: US National Institutes of Health
Conditions: HIV Infections
Interventions: GEO-D02 DNA; MVA/HIV62B Vaccine; B63521^11 gp120; IHV01 Protein; Protein Placebo
Participants: 0

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.